ID: ALA5283451

Max Phase: Preclinical

Molecular Formula: C14H10O4

Molecular Weight: 242.23

Associated Items:

Representations

Canonical SMILES:  Oc1cc2ccc3cc(O)c(O)cc3c2cc1O

Standard InChI:  InChI=1S/C14H10O4/c15-11-3-7-1-2-8-4-12(16)14(18)6-10(8)9(7)5-13(11)17/h1-6,15-18H

Standard InChI Key:  CGLAXEZXIRQOBS-UHFFFAOYSA-N

Associated Targets(Human)

SNCA Tchem Alpha-synuclein (10960 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 242.23Molecular Weight (Monoisotopic): 242.0579AlogP: 2.82#Rotatable Bonds: 0
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.78CX Basic pKa: CX LogP: 2.74CX LogD: 2.72
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.36Np Likeness Score: 0.52

References

1. Bernardes G, Munir O, Krol ES..  (2023)  The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.,  78  [PMID:36587551] [10.1016/j.bmc.2022.117147]

Source